GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ELF3
|
ENSG00000163435.11 | E74 like ETS transcription factor 3 |
EHF
|
ENSG00000135373.8 | ETS homologous factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ELF3 | hg19_v2_chr1_+_201979645_201979721 | 0.30 | 7.9e-06 | Click! |
EHF | hg19_v2_chr11_+_34642656_34642682 | 0.13 | 6.0e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 32.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
6.3 | 18.9 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
5.1 | 15.4 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
4.4 | 13.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
4.1 | 8.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
4.0 | 55.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
3.5 | 13.9 | GO:0019086 | late viral transcription(GO:0019086) |
3.5 | 10.4 | GO:0072716 | response to actinomycin D(GO:0072716) |
3.4 | 13.8 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
3.3 | 6.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) regulation of actin nucleation(GO:0051125) |
3.2 | 12.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
3.1 | 3.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
2.9 | 5.8 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
2.8 | 8.5 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) regulation of progesterone biosynthetic process(GO:2000182) |
2.7 | 8.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
2.6 | 7.8 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
2.5 | 7.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
2.4 | 7.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
2.4 | 7.3 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
2.3 | 11.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
2.3 | 30.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
2.2 | 24.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
2.1 | 12.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
2.1 | 8.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
2.0 | 16.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
2.0 | 21.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.0 | 6.0 | GO:0097359 | UDP-glucosylation(GO:0097359) |
2.0 | 19.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
1.9 | 15.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.9 | 14.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.8 | 5.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.8 | 5.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.8 | 5.4 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
1.8 | 35.7 | GO:0031167 | rRNA methylation(GO:0031167) |
1.8 | 10.6 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.7 | 5.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.7 | 5.1 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.7 | 9.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.6 | 4.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.6 | 4.9 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
1.6 | 30.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
1.6 | 6.3 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.6 | 4.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.6 | 4.7 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.6 | 9.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.5 | 4.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.5 | 9.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.5 | 6.1 | GO:0001743 | optic placode formation(GO:0001743) |
1.5 | 4.5 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
1.4 | 10.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.4 | 7.1 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
1.4 | 2.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.4 | 23.6 | GO:0006265 | DNA topological change(GO:0006265) |
1.4 | 8.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.4 | 5.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.4 | 4.1 | GO:0070781 | response to biotin(GO:0070781) |
1.4 | 6.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.3 | 8.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.3 | 3.9 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
1.3 | 15.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
1.3 | 3.8 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
1.3 | 3.8 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
1.3 | 3.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.2 | 5.0 | GO:0035962 | response to interleukin-13(GO:0035962) |
1.2 | 5.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
1.2 | 6.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
1.2 | 3.7 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
1.2 | 7.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
1.2 | 5.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) minus-end-directed organelle transport along microtubule(GO:0072385) |
1.1 | 6.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.1 | 3.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
1.1 | 3.2 | GO:0061055 | myotome development(GO:0061055) |
1.0 | 6.3 | GO:0033504 | floor plate development(GO:0033504) |
1.0 | 13.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.0 | 3.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.0 | 4.0 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
1.0 | 25.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
1.0 | 23.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.0 | 8.9 | GO:0006531 | aspartate metabolic process(GO:0006531) |
1.0 | 4.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
1.0 | 1.9 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.0 | 4.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.0 | 4.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.0 | 2.9 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.9 | 3.7 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.9 | 5.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 | 2.6 | GO:2000097 | chronological cell aging(GO:0001300) regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 2.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.9 | 9.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.9 | 2.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.9 | 3.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.9 | 11.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.8 | 13.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.8 | 9.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.8 | 9.9 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.8 | 4.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.8 | 11.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.8 | 8.7 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 4.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.8 | 12.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.8 | 6.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.8 | 11.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.8 | 2.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.8 | 4.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.7 | 2.2 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 5.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 4.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.7 | 0.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.7 | 7.8 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.7 | 2.1 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.7 | 3.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.7 | 2.8 | GO:0042335 | cuticle development(GO:0042335) |
0.7 | 5.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 4.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.7 | 3.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 4.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) secretory granule localization(GO:0032252) |
0.7 | 2.1 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.7 | 32.8 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.7 | 17.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.7 | 3.4 | GO:0030047 | actin modification(GO:0030047) |
0.7 | 2.0 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.7 | 5.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 2.7 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.7 | 3.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.7 | 2.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.7 | 2.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.7 | 15.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.6 | 3.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.6 | 4.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.6 | 1.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 6.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.6 | 4.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 17.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.6 | 1.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.6 | 3.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 1.8 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.6 | 3.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.6 | 4.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 10.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 5.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.6 | 1.7 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.6 | 4.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 1.7 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 12.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.6 | 3.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.6 | 1.7 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.5 | 15.8 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.5 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 2.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.5 | 2.1 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.5 | 2.1 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.5 | 4.2 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 1.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.5 | 3.6 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.5 | 12.7 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.5 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.5 | 1.0 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
0.5 | 2.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 7.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 0.5 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.5 | 1.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.5 | 1.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 6.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.5 | 1.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.5 | 2.8 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.5 | 3.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.5 | 1.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.5 | 3.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.5 | 5.0 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.4 | 1.3 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
0.4 | 3.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 2.6 | GO:0060011 | sperm ejaculation(GO:0042713) Sertoli cell proliferation(GO:0060011) |
0.4 | 9.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.4 | 1.7 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
0.4 | 2.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 1.3 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.4 | 15.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.4 | 2.5 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
0.4 | 16.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 4.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.4 | 2.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 2.0 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.4 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 4.9 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.4 | 1.2 | GO:1902309 | regulation of heart rate by hormone(GO:0003064) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.4 | 5.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 2.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 6.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.4 | 5.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 0.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.4 | 6.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 3.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 1.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.4 | 2.6 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.4 | 5.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 2.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.4 | 8.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 13.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.4 | 2.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 2.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 2.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 5.8 | GO:0042737 | drug catabolic process(GO:0042737) |
0.3 | 4.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 5.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.3 | 3.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 4.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.3 | 2.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.3 | 1.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 4.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 10.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.3 | 4.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 3.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 6.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 0.6 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.3 | 2.1 | GO:0071158 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) positive regulation of cell cycle arrest(GO:0071158) |
0.3 | 13.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 14.2 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.3 | 2.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 2.9 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.3 | 0.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.3 | 6.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.3 | 2.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.3 | 2.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.3 | 3.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 3.2 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 4.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 20.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 3.2 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.3 | 2.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.3 | 3.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 12.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 0.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 9.9 | GO:0042073 | intraciliary transport(GO:0042073) |
0.3 | 1.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 2.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 2.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.2 | 3.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 5.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 3.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 1.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 5.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.2 | 2.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 5.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 13.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 1.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 4.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 3.8 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 4.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 2.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 2.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 1.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 3.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 3.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 6.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 2.2 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 2.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.6 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
0.2 | 1.8 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 5.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 1.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 1.7 | GO:0001510 | RNA methylation(GO:0001510) |
0.2 | 0.6 | GO:0071258 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 0.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 1.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.9 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.2 | 1.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 1.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 3.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 8.3 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.2 | 0.9 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of lung blood pressure(GO:0061767) positive regulation of extracellular matrix assembly(GO:1901203) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.2 | 8.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.4 | GO:2000232 | regulation of ribosome biogenesis(GO:0090069) regulation of rRNA processing(GO:2000232) |
0.2 | 1.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 6.7 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 4.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.8 | GO:1902573 | positive regulation of serine-type endopeptidase activity(GO:1900005) negative regulation of sperm motility(GO:1901318) positive regulation of serine-type peptidase activity(GO:1902573) |
0.2 | 5.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 1.6 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 1.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 2.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 3.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 1.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 2.7 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.2 | 0.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 1.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 20.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 4.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.7 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 1.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 1.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 1.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 1.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.2 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
0.1 | 3.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 2.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 5.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 5.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 5.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 2.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 3.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.3 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 4.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 1.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 2.3 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 1.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 3.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 1.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 4.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 1.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 4.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 1.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 1.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 5.1 | GO:0031016 | pancreas development(GO:0031016) |
0.1 | 3.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 3.0 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 1.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.3 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 3.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 3.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 3.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 4.9 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 1.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 1.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 3.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 1.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.0 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.9 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 1.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 6.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 1.1 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.6 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 1.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 2.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 1.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.7 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 5.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 3.8 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.0 | 0.2 | GO:0021539 | subthalamus development(GO:0021539) |
0.0 | 18.0 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 0.2 | GO:0002396 | MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) |
0.0 | 0.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.2 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 2.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 2.9 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 2.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 3.5 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.0 | 1.3 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 4.6 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.7 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 1.5 | GO:0032259 | methylation(GO:0032259) |
0.0 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 3.6 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.0 | 0.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 1.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.8 | GO:1990748 | detoxification(GO:0098754) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.0 | 0.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 1.0 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 1.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.3 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.4 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
4.3 | 12.9 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
3.2 | 57.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
2.4 | 9.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.2 | 10.8 | GO:0000801 | central element(GO:0000801) |
1.8 | 11.0 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
1.8 | 21.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.7 | 5.1 | GO:0061673 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
1.6 | 4.9 | GO:0019034 | viral replication complex(GO:0019034) |
1.6 | 6.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
1.4 | 7.1 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
1.4 | 4.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.4 | 4.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.3 | 6.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
1.2 | 3.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.2 | 3.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
1.1 | 6.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.0 | 6.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.0 | 18.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.0 | 13.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.0 | 5.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.9 | 2.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.9 | 4.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.8 | 21.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.8 | 3.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.7 | 4.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.7 | 9.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 0.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.7 | 2.7 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.7 | 2.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 2.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 12.2 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 7.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.6 | 3.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 2.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 64.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.6 | 2.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 3.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 7.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 4.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.5 | 10.3 | GO:0044447 | axoneme part(GO:0044447) |
0.5 | 3.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 2.4 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 12.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 2.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.5 | 11.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 6.7 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 3.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 12.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.4 | 1.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 2.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 2.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 56.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 8.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 4.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.4 | 1.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.3 | 5.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 4.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 9.6 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 19.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 3.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 4.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 3.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 4.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 1.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 6.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 3.9 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.3 | 5.5 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.3 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 35.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 14.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 4.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 2.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 8.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 3.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 6.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 19.3 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 4.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 3.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 7.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 7.4 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 1.2 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 1.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 4.9 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 11.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 1.0 | GO:0036019 | endolysosome(GO:0036019) |
0.2 | 8.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 2.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 15.5 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 12.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 2.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 6.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 0.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 5.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 5.6 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 2.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 3.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 8.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 2.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 11.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 4.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 1.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 5.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 14.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 3.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 36.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 1.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 3.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 3.4 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 6.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 6.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) postsynaptic endosome(GO:0098845) |
0.1 | 5.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 6.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 2.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 3.7 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 19.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 3.4 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.1 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 9.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 2.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 2.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 4.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 10.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.7 | GO:0030424 | axon(GO:0030424) |
0.0 | 2.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 6.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 139.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 2.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 2.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 2.2 | GO:0019867 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.0 | 0.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 1.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 1.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 2.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 2.9 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 26.2 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0031514 | motile cilium(GO:0031514) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 36.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
6.6 | 19.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
6.3 | 31.5 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
5.1 | 15.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
5.1 | 15.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.5 | 27.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
3.1 | 9.4 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
3.0 | 8.9 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.7 | 8.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
2.4 | 7.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
2.1 | 6.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
2.0 | 6.0 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
2.0 | 21.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.0 | 3.9 | GO:0020037 | heme binding(GO:0020037) |
1.9 | 7.8 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.8 | 3.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.7 | 8.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
1.7 | 6.7 | GO:0004803 | transposase activity(GO:0004803) |
1.6 | 8.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.6 | 4.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
1.5 | 6.2 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
1.4 | 4.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
1.4 | 18.5 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
1.4 | 11.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.4 | 5.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.4 | 5.5 | GO:0032810 | sterol response element binding(GO:0032810) |
1.4 | 8.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
1.4 | 6.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.3 | 8.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.3 | 20.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.3 | 4.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.3 | 6.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.3 | 5.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.2 | 5.0 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.2 | 3.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 6.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.1 | 3.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.1 | 19.7 | GO:0005522 | profilin binding(GO:0005522) |
1.1 | 16.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 5.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 19.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.0 | 14.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.0 | 13.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 8.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.0 | 7.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.9 | 3.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.9 | 5.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.9 | 10.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.9 | 9.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.8 | 23.2 | GO:0071949 | FAD binding(GO:0071949) |
0.8 | 14.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.8 | 5.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.8 | 6.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.8 | 9.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 2.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.7 | 7.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.7 | 3.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.7 | 4.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.7 | 4.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.7 | 2.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.7 | 2.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 2.7 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.7 | 13.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 2.7 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.6 | 3.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.6 | 6.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.6 | 2.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 3.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 8.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.6 | 9.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 35.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.6 | 5.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.6 | 2.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 4.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.6 | 4.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 2.9 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.6 | 4.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.6 | 1.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.6 | 1.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.6 | 4.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 1.7 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.6 | 1.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 9.3 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 17.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 3.8 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.5 | 2.1 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.5 | 2.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.5 | 1.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.5 | 1.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.5 | 13.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 10.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.5 | 1.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.5 | 11.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 10.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 1.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 2.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 1.7 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.4 | 1.7 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.4 | 4.1 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 4.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 2.0 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.4 | 4.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 4.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 5.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 7.0 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 3.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 4.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 7.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 4.1 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.4 | 3.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 6.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 5.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 34.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.3 | 2.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 9.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 8.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 3.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.3 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.3 | 2.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 2.0 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.3 | 1.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 3.3 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 5.5 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 4.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 13.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 12.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 8.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 3.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 3.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 2.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 2.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 2.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 3.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 4.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 3.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 1.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.3 | 4.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 5.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 2.1 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 0.8 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.3 | 14.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 2.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 2.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 2.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 6.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 7.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 12.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 4.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 1.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 2.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 2.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.2 | 9.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 3.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 3.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.2 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 5.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 19.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 2.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 1.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.2 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 5.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 1.9 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.2 | 2.1 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 1.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 1.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 5.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 7.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 8.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 2.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 8.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 2.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 2.6 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 11.7 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 2.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 4.5 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 0.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.2 | 0.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 17.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 5.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 5.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 3.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.2 | 3.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 4.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 24.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 15.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 1.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 10.8 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 181.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 19.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 3.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 3.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 1.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.6 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 1.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.9 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 1.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 2.8 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 1.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 1.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.1 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 2.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 1.0 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 2.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 2.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 2.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 37.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 4.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.1 | 0.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 3.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 9.3 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 6.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 8.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 4.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 3.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 2.4 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 2.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 4.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 1.0 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 2.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 15.0 | GO:0046873 | metal ion transmembrane transporter activity(GO:0046873) |
0.0 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 9.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.5 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 6.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.8 | 28.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 3.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 21.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 42.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 33.1 | PID ATM PATHWAY | ATM pathway |
0.5 | 13.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 14.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 4.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 5.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 17.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 14.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 8.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 13.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 7.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 14.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 24.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 10.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 26.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 5.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 5.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 8.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 23.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 22.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 3.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 6.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 9.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 12.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 13.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 2.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 10.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 9.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 6.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 5.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 9.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 7.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 5.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 4.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 4.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 4.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 25.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 7.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 4.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 7.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.8 | 9.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.8 | 1.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.8 | 24.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 3.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 19.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.6 | 16.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.6 | 4.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 15.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 25.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 7.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 6.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 24.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 9.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 135.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.4 | 6.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 2.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 11.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 4.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 6.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 17.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 4.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 8.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 4.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 1.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 17.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 8.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 13.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 2.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 6.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 7.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 6.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 7.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 4.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 10.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 3.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 5.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 7.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 3.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 7.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 4.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 2.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 3.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 3.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 5.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 6.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 3.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 5.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 5.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 3.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 4.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 3.8 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 1.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 5.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 5.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 11.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 5.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 7.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 4.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 3.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 4.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 6.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 2.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 3.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |